ClinVar Miner

Submissions for variant NM_002180.3(IGHMBP2):c.138T>A (p.Cys46Ter)

gnomAD frequency: 0.00001  dbSNP: rs372000714
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000255598 SCV000321772 pathogenic not provided 2023-01-11 criteria provided, single submitter clinical testing Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 14681881, 33210134, 34426522, 25439726, 25568292)
Invitae RCV000550952 SCV000642304 pathogenic Autosomal recessive distal spinal muscular atrophy 1; Charcot-Marie-Tooth disease axonal type 2S 2023-12-12 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Cys46*) in the IGHMBP2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IGHMBP2 are known to be pathogenic (PMID: 14681881, 25439726, 25568292). This variant is present in population databases (rs372000714, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with spinal muscular atrophy with respiratory distress 1 and Charcot-Marie-Tooth disease type 2 (PMID: 14681881, 25439726, 25568292). ClinVar contains an entry for this variant (Variation ID: 162194). For these reasons, this variant has been classified as Pathogenic.
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München RCV000995566 SCV001149808 pathogenic Autosomal recessive distal spinal muscular atrophy 1 2018-08-14 criteria provided, single submitter clinical testing
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV000995566 SCV001368450 pathogenic Autosomal recessive distal spinal muscular atrophy 1 2020-03-31 criteria provided, single submitter clinical testing This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS4,PM2,PM3. This variant was detected in homozygous state.
Kariminejad - Najmabadi Pathology & Genetics Center RCV001814070 SCV001755567 pathogenic Peripheral neuropathy 2021-07-10 criteria provided, single submitter clinical testing
Ambry Genetics RCV002390316 SCV002698376 pathogenic Inborn genetic diseases 2021-05-11 criteria provided, single submitter clinical testing The p.C46* pathogenic mutation (also known as c.138T>A), located in coding exon 2 of the IGHMBP2 gene, results from a T to A substitution at nucleotide position 138. This changes the amino acid from a cysteine to a stop codon within coding exon 2. This variant was detected as compound heterozygous with another mutation in IGHMBP2 in multiple individuals with Charcot-Marie-Tooth disease type 2 (Cottenie E et al. Am J Hum Genet, 2014 Nov;95:590-601; Schottmann G et al. Neurology, 2015 Feb;84:523-31). This variant was also detected in an individual with distal spinal muscular atrophy 1 with respiratory distress (SMARD1) (Grohmann K et al. Ann Neurol, 2003 Dec;54:719-24). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV000995566 SCV003761314 pathogenic Autosomal recessive distal spinal muscular atrophy 1 2023-01-25 criteria provided, single submitter curation The heterozygous p.Cys46Ter variant in IGHMBP2 was identified by our study, in the compound heterozygous state with a variant of uncertain significance (dbSNP ID: rs1449942315), in one individual with distal spinal muscular atrophy. This individual also carried a variant of uncertain significance (dbSNP ID: rs1449942315); however, the phase of these variants are unknown at this time. The p.Cys46Ter variant in IGHMBP2 has been previously reported in 5 unrelated individuals with autosomal recessive IGHMBP2-related neurological disease (PMID: 25568292, PMID: 25439726, PMID: 14681881) and segregated with disease in 7 affected relatives from 4 families (PMID: 25439726, PMID: 25568292), but has been identified in 0.0035% (4/113764) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs372000714). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. Of these 5 affected individuals (PMID: 25568292, PMID: 25439726, PMID: 14681881), 4 were compound heterozygotes who carried pathogenic or likely pathogenic variants in trans (PMID: 25568292, ClinVar Variation ID: 162195; PMID: 25439726, ClinVar Variation ID: 162195; PMID: 14681881), which increases the likelihood that the p.Cys46Ter variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 162194) and has been interpreted as pathogenic by multiple submitters. This nonsense variant leads to a premature termination codon at position 46, which is predicted to lead to a truncated or absent protein. Loss of function of the IGHMBP2 gene is strongly associated to autosomal recessive distal spinal muscular atrophy 1. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive distal spinal muscular atrophy 1. ACMG/AMP Criteria applied: PVS1_Strong, PM2_Supporting, PM3_VeryStrong, PP1_Moderate (Richards 2015).
OMIM RCV000149574 SCV000196550 pathogenic Charcot-Marie-Tooth disease axonal type 2S 2015-02-03 no assertion criteria provided literature only
Inherited Neuropathy Consortium RCV000790277 SCV000929681 uncertain significance Distal spinal muscular atrophy no assertion criteria provided literature only
Clinical Genetics, Academic Medical Center RCV000255598 SCV001922331 pathogenic not provided no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000255598 SCV001963176 pathogenic not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.